Other
OCI Unrealized Holding Gain (Loss) on Securities, Net of Tax
Year-over-year, this metric declined by 454.6%, from $1.03M to -$3.65M. Over 3 years (FY 2021 to FY 2025), OCI Unrealized Holding Gain (Loss) on Securities, Net of Tax shows an upward trend with a -2.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOther
CategoryRisk
SignalHigher is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Reflects the net impact of market movements on the company's book value and overall financial position.
Detailed definition
The change in fair value of investment securities held in the portfolio, net of applicable tax effects. This provides a...
Peer comparison
Standard metric for reporting the impact of market value changes on equity in insurance financial statements.
Metric ID:
ms_oci_unrealized_holding_gain_loss_securities_net_of_taxHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$247.00K | -$64.00K | -$1.67M | -$7.22M | -$1.73M | -$2.05M | $4.13M | -$2.03M | $1.88M | $7.04M | -$3.57M | -$727.00K | $9.08M | -$4.79M | $1.03M | -$343.00K | $1.13M | $0.00 | -$3.65M |
| QoQ Change | — | +74.1% | <-999% | -333.2% | +76.0% | -18.4% | +300.9% | -149.1% | +192.7% | +274.9% | -150.7% | +79.6% | >999% | -152.7% | +121.5% | -133.3% | +429.7% | -100.0% | — |
| YoY Change | — | — | — | — | -602.0% | <-999% | +157.2% | -16.8% | +191.5% | — | -186.5% | +64.1% | +383.4% | -168.0% | +128.9% | +52.8% | -87.5% | +100.0% | -454.6% |
Range-$7.22M – $9.08M
CAGR+82.0%
Avg YoY Growth-253.2%
Median YoY Growth+18.0%
Current Streak2 quarters decline
OCI Unrealized Holding Gain (Loss) on Securities, Net of Tax at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's oci unrealized holding gain (loss) on securities, net of tax?
- Alnylam Pharmaceuticals (ALNY) reported oci unrealized holding gain (loss) on securities, net of tax of -$3.65M in Q1 2026.
- How has Alnylam Pharmaceuticals's oci unrealized holding gain (loss) on securities, net of tax changed year-over-year?
- Alnylam Pharmaceuticals's oci unrealized holding gain (loss) on securities, net of tax decreased by 454.6% year-over-year, from $1.03M to -$3.65M.
- What is the long-term trend for Alnylam Pharmaceuticals's oci unrealized holding gain (loss) on securities, net of tax?
- Over 3 years (2021 to 2025), Alnylam Pharmaceuticals's oci unrealized holding gain (loss) on securities, net of tax has grown at a -2.8% compound annual growth rate (CAGR), from -$1.98M to $1.82M.
- What does oci unrealized holding gain (loss) on securities, net of tax mean?
- The after-tax change in the value of investment holdings that have not been sold.